Classification and Actionability Indices for Lung Cancer
    1.
    发明申请
    Classification and Actionability Indices for Lung Cancer 审中-公开
    肺癌分类及可行性指标

    公开(公告)号:US20160265065A1

    公开(公告)日:2016-09-15

    申请号:US15068011

    申请日:2016-03-11

    CPC classification number: C12Q1/6886 C12Q2600/106 C12Q2600/156

    Abstract: The disclosure provides compositions, kits, and methods for detecting a plurality of genes and associated variants in a sample from a subject with lung cancer. The compositions, kits, and methods include a set of oligonucleotides, typically primers and/or probes that can hybridize to identify a gene variant. The methods disclosed herein provide for a mutation status of a tumor to be determined and subsequently associated with an actionable treatment recommendation.

    Abstract translation: 本公开提供了用于检测来自患有肺癌的受试者的样品中的多种基因和相关变体的组合物,试剂盒和方法。 组合物,试剂盒和方法包括一组寡核苷酸,通常可以杂交以鉴定基因变体的引物和/或探针。 本文公开的方法提供待确定的肿瘤的突变状态,并随后与可行动治疗推荐相关联。

    Classification and Actionability Indices for Lung Cancer
    4.
    发明申请
    Classification and Actionability Indices for Lung Cancer 审中-公开
    肺癌分类及可行性指标

    公开(公告)号:US20140288116A1

    公开(公告)日:2014-09-25

    申请号:US14212115

    申请日:2014-03-14

    CPC classification number: C12Q1/6886 C12Q2600/106 C12Q2600/156

    Abstract: The disclosure provides compositions, kits, and methods for detecting a plurality of genes and associated variants in a sample from a subject with lung cancer. The compositions, kits, and methods include a set of oligonucleotides, typically primers and/or probes that can hybridize to identify a gene variant. The methods disclosed herein provide for a mutation status of a tumor to be determined and subsequently associated with an actionable treatment recommendation.

    Abstract translation: 本公开提供了用于检测来自患有肺癌的受试者的样品中的多种基因和相关变体的组合物,试剂盒和方法。 组合物,试剂盒和方法包括一组寡核苷酸,通常可以杂交以鉴定基因变体的引物和/或探针。 本文公开的方法提供待确定的肿瘤的突变状态,并随后与可行动治疗推荐相关联。

Patent Agency Ranking